Skip to main content

Altimmune CEO Bill Enright to depart – Washington Business Journal

By October 29, 2018News
enright-bill-vaxin-image

enright-bill-vaxin-image

The chief executive will stay in his role, and on the board, until his successor is appointed or early next year, whichever comes first.

{iframe}https://www.bizjournals.com/washington/news/2018/10/23/gaithersburg-biotech-ceo-to-step-down.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.